Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Change in Inventory (2016 - 2025)

Conmed's Change in Inventory history spans 16 years, with the latest figure at -$8.5 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 218.23% year-over-year to -$8.5 million; the TTM value through Dec 2025 reached $6.7 million, down 78.72%, while the annual FY2025 figure was $6.7 million, 78.72% down from the prior year.
  • Change in Inventory reached -$8.5 million in Q4 2025 per CNMD's latest filing, down from $2.2 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $26.4 million in Q4 2022 to a low of -$8.8 million in Q4 2023.
  • Average Change in Inventory over 5 years is $7.0 million, with a median of $5.3 million recorded in 2021.
  • Peak YoY movement for Change in Inventory: soared 2378.85% in 2024, then plummeted 218.23% in 2025.
  • A 5-year view of Change in Inventory shows it stood at $3.1 million in 2021, then skyrocketed by 745.47% to $26.4 million in 2022, then crashed by 133.23% to -$8.8 million in 2023, then skyrocketed by 181.92% to $7.2 million in 2024, then tumbled by 218.23% to -$8.5 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Change in Inventory are -$8.5 million (Q4 2025), $2.2 million (Q3 2025), and $5.6 million (Q2 2025).